Segment Information

6 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

SEGMENT INFORMATION

NOTE 9:- SEGMENT INFORMATION

a. The Company conducts its operations through two reporting segments. The following segment identification is identical to the segment identification used in the Company’s latest annual audited consolidated financial report.

b. The following presents segment results of operations for the six months ended June 30, 2018 (unaudited):

	Cellocator segment		MRM segment		Elimination			Total
Segments revenues	$	12,729	$	32,304	$	(4,410	)	$	40,623
Segments operating profit		1,201		4,405		(281	)		5,325
Segments tangible and intangible assets		8,751		35,144		1,557			45,452
Depreciation and amortization		86		1,259		-			1,345
Expenditures for assets		82		1,551		-			1,633

c. The following presents segment results of operations for the six months ended June 30, 2017 (unaudited):

	Cellocator segment		MRM segment		Elimination			Total
Segments revenues	$	12,535	$	30,502	$	(3,965	)	$	39,072
Segments operating profit		1,150		3,471		469			5,090
Segments tangible and intangible assets		8,943		37,403		2,104			48,450
Depreciation and amortization		67		1,384		-			1,451
Expenditures for assets		102		1,010		-			1,112

d. The following presents segment results of operations for the three months ended June 30, 2018 (unaudited):

	Cellocator segment		MRM segment		Elimination			Total
Segments revenues	$	6,159	$	15,593	$	(2,012	)	$	19,740
Segments operating profit		492		2,380		(114	)		2,758
Segments tangible and intangible assets		8,751		35,144		1,557			45,452
Depreciation and amortization		43		584		-			627
Expenditures for assets		39		635		-			674

e. The following presents segment results of operations for the three months ended June 30, 2017 (unaudited):

	Cellocator segment		MRM segment		Elimination			Total
Segments revenues	$	6,383	$	15,576	$	(1,918	)	$	20,041
Segments operating profit		699		1,798		337			2,834
Segments tangible and intangible assets		8,943		37,403		2,104			48,450
Depreciation and amortization		34		567		-			601
Expenditures for assets		44		300		-			344

f. The following presents segment results of operations for the year ended December 31, 2017:

	Cellocator segment		MRM segment		Elimination			Total
Segments revenues	$	24,364	$	62,208	$	(8,417	)	$	78,155
Segments operating profit		2,742		7,569		(2	)		10,309
Segments tangible and intangible assets		9,026		37,799		1,968			48,793
Depreciation, amortization and impairment expenses		144		2,780		-			2,924
Expenditures for assets		197		3,069		-			3,266